4//SEC Filing
Klompas Neil A 4
Accession 0000899243-22-010795
CIK 0001403752other
Filed
Mar 10, 7:00 PM ET
Accepted
Mar 11, 9:00 PM ET
Size
17.3 KB
Accession
0000899243-22-010795
Insider Transaction Report
Form 4
Zymeworks Inc.ZYME
Klompas Neil A
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Shares
2022-03-10+2,500→ 13,547 total - Sale
Common Shares
2022-03-10$6.88/sh−2,979$20,496→ 13,276 total - Exercise/Conversion
Restricted Stock Unit
2022-03-10−2,708→ 5,417 total→ Common Shares (2,708 underlying) - Exercise/Conversion
Common Shares
2022-03-10+2,708→ 16,255 total - Exercise/Conversion
Restricted Stock Unit
2022-03-10−2,500→ 2,500 total→ Common Shares (2,500 underlying) - Award
Stock Option (Right to Buy)
2022-03-10+200,000→ 200,000 totalExercise: $7.00Exp: 2032-03-09→ Common Shares (200,000 underlying)
Holdings
- 700(indirect: By Spouse)
Common Shares
Footnotes (8)
- [F1]Represents common shares issued upon vesting of one third of the restricted stock units ("RSUs") granted on March 10, 2020.
- [F2]Represents common shares issued upon vesting of one third of the RSUs granted on March 10, 2021.
- [F3]Represents common shares sold to cover tax withholding obligations and other applicable fees in connection with the vesting of RSUs. Pursuant to the terms of the applicable RSU grant agreement (each, a "Grant Agreement"), effective on the grant date of the RSUs, the Reporting Person adopted a 10b5-1 plan pursuant to which the Reporting Person elected to sell shares to cover tax withholding obligations and other applicable fees in accordance with the terms of the Grant Agreement. The Reporting Person is subject to a Lock Up Agreement that expires on March 27, 2022. The sale of shares is a permissible exemption under the terms of the Lock Up Agreement. The remaining shares held by the Reporting Person following this sale remain subject to the terms of the Lock Up Agreement.
- [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.83 to $6.97, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- [F5]Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
- [F6]The RSUs were granted on March 10, 2020 and vest in three equal annual instalments beginning on March 10, 2021.
- [F7]The RSUs were granted on March 10, 2021 and vest in three equal annual instalments beginning on March 10, 2022.
- [F8]Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following first anniversary of grant date.
Documents
Issuer
Zymeworks Inc.
CIK 0001403752
Entity typeother
Related Parties
1- filerCIK 0001761857
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 7:00 PM ET
- Accepted
- Mar 11, 9:00 PM ET
- Size
- 17.3 KB